Polar Capital Holdings PLC Bicycle Therapeutics PLC Transaction History

Polar Capital Holdings PLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$19.58 - $27.24 $34,362 - $47,806	-1,755 Reduced 0.17%	1,002,780 $22.7 Million
Q4 2023 Feb 14, 2024	SELL	$13.29 - $22.2 $92,564 - $154,623	-6,965 Reduced 0.69%	1,004,535 $18.2 Million
Q3 2023 Nov 14, 2023	BUY	$19.9 - $26.25 $5.01 Million - $6.62 Million	252,000 Added 33.18%	1,011,500 $20.3 Million
Q2 2023 Dec 13, 2023	SELL	$18.95 - $28.67 $4.74 Million - $7.17 Million	-250,000 Reduced 24.76%	759,500 $19.4 Million
Q2 2023 Aug 14, 2023	SELL	$18.95 - $28.67 $4.74 Million - $7.17 Million	-250,000 Reduced 24.76%	759,500 $19.4 Million
Q1 2023 Dec 13, 2023	SELL	$20.02 - $31.37 $40,040 - $62,740	-2,000 Reduced 0.2%	1,009,500 $21.5 Million
Q1 2023 May 15, 2023	BUY	$20.02 - $31.37 $5.2 Million - $8.14 Million	259,500 Added 34.6%	1,009,500 $21.5 Million
Q4 2022 Feb 14, 2023	BUY	$20.37 - $32.9 $15.3 Million - $24.7 Million	750,000 New	750,000 $22.2 Million

104

42.9M

12.1K

17.4K

Ticker BCYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,676,100
Market Cap $308M
Description
Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...

Get notified when there are updates to the investment portfolio of Polar Capital Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Polar Capital Holdings PLC with notifications on news.